APA (7th ed.) Citation

Behr-Roussel, D., Oger, S., Pignol, B., Pham, E., Le, M. A., Chabrier, P., . . . Denys, P. (2012). 462 Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO). European Urology Supplements, 11(1), e462. https://doi.org/10.1016/S1569-9056(12)60459-X

Chicago Style (17th ed.) Citation

Behr-Roussel, D., et al. "462 Minimal Effective Dose (MED) of OnabotulinumtoxinA (onaBoNT-A) and AbobotulinumtoxinA (aboBoNT-A) in a Rat Model of Neurogenic Detrusor Overactivity (NDO)." European Urology Supplements 11, no. 1 (2012): e462. https://doi.org/10.1016/S1569-9056(12)60459-X.

MLA (9th ed.) Citation

Behr-Roussel, D., et al. "462 Minimal Effective Dose (MED) of OnabotulinumtoxinA (onaBoNT-A) and AbobotulinumtoxinA (aboBoNT-A) in a Rat Model of Neurogenic Detrusor Overactivity (NDO)." European Urology Supplements, vol. 11, no. 1, 2012, p. e462, https://doi.org/10.1016/S1569-9056(12)60459-X.